Amplified Innovation, Amplified Impact

Diagnostic test development demands raw materials that perform consistently, even as workflows grow more complex and timelines tighten. This ultra-pure molecular diagnostics portfolio addresses one of the most persistent risks in assay development: contamination that can compromise accuracy and confidence in results. Each enzyme, reagent, and isolation component is purified to stringent quality levels to minimize DNA, RNase, DNase, and nickase contaminants, helping reduce false positives and negatives across PCR, RT-PCR, LAMP, and sample preparation workflows. The portfolio spans high-performance polymerases, hot-start Taq, RT enzymes, PCR reagents, and magnetic bead–based viral RNA and cfDNA isolation kits designed for speed, automation, and reproducibility. Together, these materials support reliable detection from sample collection through amplification.

Explore the full brochure to see how ultra-pure inputs can strengthen assay performance at every stage.